# OnCo record tumour-flare-on-bispecific-antibodies-and-immunomodulatory-drugs (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/tumour-flare-on-bispecific-antibodies-and-immunomodulatory-drugs/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "tumour-flare-on-bispecific-antibodies-and-immunomodulatory-drugs" ;
  schema:name "Tumour flare on bispecific antibodies and lenalidomide in lymphoma: recognition and management"@en ;
  schema:alternateName "tumour flare"@en, "tumor flare"@en, "tumour flare reaction"@en, "TFR"@en, "pseudoprogression in lymphoma"@en, "pseudo-progression"@en, "flare reaction on glofitamab"@en, "lenalidomide tumour flare"@en, "indeterminate response"@en ;
  schema:description "Some lymphoma medicines draw immune cells into the lymphoma, so lumps can swell and hurt for days or sometimes weeks. This is tumour flare, and it can look like the cancer growing when it is not. Painkillers and sometimes steroids are used. A lump near the windpipe or another vital organ can press on it, so tell your team straight away about swollen or sore lumps, chest pain or trouble breathing."@en ;
  schema:url <https://onco.cc/protocols/tumour-flare-on-bispecific-antibodies-and-immunomodulatory-drugs/> ;
  schema:dateModified "2026-11-17"^^xsd:date ;
  onco:related <https://onco.cc/protocols/bispecific-step-up-dosing/>, <https://onco.cc/protocols/crs-grading-and-management/>, <https://onco.cc/protocols/tumour-lysis-syndrome-prevention-and-treatment/>, <https://onco.cc/protocols/svc-obstruction/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/glofitamab/>, <https://onco.cc/drugs/mosunetuzumab/>, <https://onco.cc/drugs/epcoritamab/>, <https://onco.cc/drugs/lenalidomide/> ;
  onco:terms <https://onco.cc/terms/crs/>, <https://onco.cc/terms/imid/>, <https://onco.cc/terms/lugano-classification/>, <https://onco.cc/terms/tumor-lysis-syndrome/> .
